FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385980097> ?p ?o ?g. }

• W4385980097 abstract "Abstract Background We investigated the associations between the different dose of tigecycline, its efficacy and safety, and the role of tigecycline therapeutic drug monitoring for patients in intensive care unit. Methods This was a single-center cohort study including patients with Multidrug-Resistant Acinetobacter baumannii , (MDR-AB)and Multidrug-Resistant Klebsiella pneumoniae (MDR-KP) pulmonary infections admitted to the ICU between October 2020 and December 2021. The steady-state plasma concentration after tigecycline administration was determined by the High Performance Liquid Chromatography (HPLC) method. Multivariate analysis of the clinical efficacy and safety of tigecycline were performed to control cofounding factors. Results This study included 45 patients, and a total of 45 blood samples were collected to determine steady-state trough concentrations of tigecycline. All patients were divided into High Dose (HD) group and Standard Dose (SD) group. The median trough concentration of tigecycline was 0.56µg/mL in the HD group, which was higher than in the SD group(0,21µg/mL),p = 0.000. There was no significant difference between the two groups of patients in terms of bacterial eradication rate, mortality rate and clinical efficacy. Multiple regression analysis showed that ICU days was correlated with mortality OR 1.030(1.005–1.056), p = 0.017. APACHE II was significantly associated with clinical efficacy OR 0.870(0.755–1.002),p = 0.045. The level of fibrinogen decline in the HD group was significantly higher than that in the SD group(-3.05 ± 1.67 vs -1.75 ± 1.90),p = 0.038. Age and tigecycline treatment duration were identified as influencing factors for fibrinogen decline. Conclusions Tigecycline plasma concentrations are significantly increased when using a high dose. However, the plasma concentration of tigecycline is not correlated with clinical efficacy and adverse reactions. Fibrinogen decline appears to be related to patient age and days of tigecycline. Large sample data are still needed to confirm the clinical guidance significance of tigecycline TDM." @default.
• W4385980097 created "2023-08-19" @default.
• W4385980097 creator A5003642180 @default.
• W4385980097 creator A5011220640 @default.
• W4385980097 creator A5011978349 @default.
• W4385980097 creator A5017763539 @default.
• W4385980097 creator A5025565899 @default.
• W4385980097 creator A5029117633 @default.
• W4385980097 creator A5034752440 @default.
• W4385980097 creator A5039737834 @default.
• W4385980097 creator A5050590703 @default.
• W4385980097 creator A5051874918 @default.
• W4385980097 creator A5073032439 @default.
• W4385980097 date "2023-08-18" @default.
• W4385980097 modified "2023-10-17" @default.
• W4385980097 title "Clinical Efficacy and Safety of Tigecycline Based on Therapeutic Drug Monitoring for Carbapenem- Resistant Gram Negative Bacterium Pneumonia in Intensive Care Units" @default.
• W4385980097 cites W1983269321 @default.
• W4385980097 cites W1994342215 @default.
• W4385980097 cites W2024928375 @default.
• W4385980097 cites W2033863918 @default.
• W4385980097 cites W2039470277 @default.
• W4385980097 cites W2060669911 @default.
• W4385980097 cites W2151958462 @default.
• W4385980097 cites W2336621586 @default.
• W4385980097 cites W2473016454 @default.
• W4385980097 cites W2590739893 @default.
• W4385980097 cites W2605062914 @default.
• W4385980097 cites W2751527751 @default.
• W4385980097 cites W3003235840 @default.
• W4385980097 cites W3014508302 @default.
• W4385980097 cites W3022327571 @default.
• W4385980097 cites W3033524616 @default.
• W4385980097 cites W3082083615 @default.
• W4385980097 cites W3082444736 @default.
• W4385980097 cites W3111685685 @default.
• W4385980097 cites W3119043475 @default.
• W4385980097 cites W3152527231 @default.
• W4385980097 cites W3189307967 @default.
• W4385980097 cites W3210843874 @default.
• W4385980097 cites W4220656053 @default.
• W4385980097 cites W4220831896 @default.
• W4385980097 cites W4224266833 @default.
• W4385980097 cites W4285092034 @default.
• W4385980097 cites W4288038175 @default.
• W4385980097 cites W4317359099 @default.
• W4385980097 doi "https://doi.org/10.21203/rs.3.rs-3140601/v1" @default.
• W4385980097 hasPublicationYear "2023" @default.
• W4385980097 type Work @default.
• W4385980097 citedByCount "0" @default.
• W4385980097 crossrefType "posted-content" @default.
• W4385980097 hasAuthorship W4385980097A5003642180 @default.
• W4385980097 hasAuthorship W4385980097A5011220640 @default.
• W4385980097 hasAuthorship W4385980097A5011978349 @default.
• W4385980097 hasAuthorship W4385980097A5017763539 @default.
• W4385980097 hasAuthorship W4385980097A5025565899 @default.
• W4385980097 hasAuthorship W4385980097A5029117633 @default.
• W4385980097 hasAuthorship W4385980097A5034752440 @default.
• W4385980097 hasAuthorship W4385980097A5039737834 @default.
• W4385980097 hasAuthorship W4385980097A5050590703 @default.
• W4385980097 hasAuthorship W4385980097A5051874918 @default.
• W4385980097 hasAuthorship W4385980097A5073032439 @default.
• W4385980097 hasBestOaLocation W43859800971 @default.
• W4385980097 hasConcept C112705442 @default.
• W4385980097 hasConcept C126322002 @default.
• W4385980097 hasConcept C2776315533 @default.
• W4385980097 hasConcept C2776376669 @default.
• W4385980097 hasConcept C2777027569 @default.
• W4385980097 hasConcept C2777637488 @default.
• W4385980097 hasConcept C2780272996 @default.
• W4385980097 hasConcept C501593827 @default.
• W4385980097 hasConcept C523546767 @default.
• W4385980097 hasConcept C54355233 @default.
• W4385980097 hasConcept C71924100 @default.
• W4385980097 hasConcept C86803240 @default.
• W4385980097 hasConcept C89423630 @default.
• W4385980097 hasConcept C90924648 @default.
• W4385980097 hasConceptScore W4385980097C112705442 @default.
• W4385980097 hasConceptScore W4385980097C126322002 @default.
• W4385980097 hasConceptScore W4385980097C2776315533 @default.
• W4385980097 hasConceptScore W4385980097C2776376669 @default.
• W4385980097 hasConceptScore W4385980097C2777027569 @default.
• W4385980097 hasConceptScore W4385980097C2777637488 @default.
• W4385980097 hasConceptScore W4385980097C2780272996 @default.
• W4385980097 hasConceptScore W4385980097C501593827 @default.
• W4385980097 hasConceptScore W4385980097C523546767 @default.
• W4385980097 hasConceptScore W4385980097C54355233 @default.
• W4385980097 hasConceptScore W4385980097C71924100 @default.
• W4385980097 hasConceptScore W4385980097C86803240 @default.
• W4385980097 hasConceptScore W4385980097C89423630 @default.
• W4385980097 hasConceptScore W4385980097C90924648 @default.
• W4385980097 hasLocation W43859800971 @default.
• W4385980097 hasOpenAccess W4385980097 @default.
• W4385980097 hasPrimaryLocation W43859800971 @default.
• W4385980097 hasRelatedWork W107149970 @default.
• W4385980097 hasRelatedWork W2152973319 @default.
• W4385980097 hasRelatedWork W2186531448 @default.
• W4385980097 hasRelatedWork W2367725957 @default.
• W4385980097 hasRelatedWork W2433702746 @default.
• W4385980097 hasRelatedWork W2540732822 @default.
• W4385980097 hasRelatedWork W4205816117 @default.

• next